期刊文献+

眼眶及脑部肿瘤磁共振波谱的应用 被引量:1

New applications of MRS in orbital and brain tumor
下载PDF
导出
摘要 磁共振波谱(magnetic resonance spectros- copy,MRS)技术是研究眼眶及脑部肿瘤物质和能量代谢的有效方法,它可有助于脑肿瘤和眼眶肿瘤的诊断和鉴别诊断,能提供组织学分级、术后复发、疗效评价等重要信息。本文叙述了1HMRS(proton magnetic resonance spectroscopy)的基本工作原理及化合物分析的意义,阐明了不同肿瘤各化合物不同含量所引起的1HMRS的变化,并介绍了1HMRS在眼及脑肿瘤方面的应用现状。 Magnetic Resonance Spectroscopy (MRS) is a powerful method for the study of composition and energetic metabolism of orbital and brain tumor. It is very helpful for the diagnosis and differentiation of orbital and brain tumor with the information about histologic grading, postoperative recurrence and therapeutic evaluation. This article reviews basic work principle of 1HMRS(proton Magnetic Resonance Spectroscopy)and significance of compound analysis; it clarifies change in 1HMRS caused by the aniso-content of compound in different kinds of tumor; it recommends the clinical application of 1HMRS in orbital and brain tumor as well.·
出处 《国际眼科杂志》 CAS 2004年第1期132-136,共5页 International Eye Science
关键词 眼眶 脑部肿瘤 磁共振波谱 MRS 诊断 治疗 magnetic resonance spectroscopy orbital tumor brain tumor metabolism diagnosis
  • 相关文献

参考文献12

  • 1Castillo M, Kwock L, Mukherji SK. Clinical applications of Proton MR spectroscopy. Am J Neuroraoiol, 1996;17(1): 1-15
  • 2Koeze TH. In vivo nuclear magnetic resonance spectroscopy of a transplanted brain tumor. Br J Cancer, 1984;49(3):357-361
  • 3Tien RB, Lai PH, Smith JS. Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. AJR, 1996;167(1):201-209
  • 4Norfray JF, Tomita T, Byrd S. Clinical impact of MR spectroscopy when MR imaging is indeterminate for pediatric brain tumors. AJR, 1999;173:119-125
  • 5Negendank WG, Sauter R, Brown TR. 1H-MRS in patients with glial tumors:a multicenter study.JNeurosing, 1996;84:449-458
  • 60Kinishita Y, Kajiwara H, Yokota A. Proton MR spectroscopy of brain tumors: a votro study.Neurosurgery, 1994;35:606-614
  • 7Castillo M, Smith JK, Kwock L. Correlation of myo-inosital levels and grading of cerebral astrocytomas. Am J Neuoradiol, 2000;21:1645-1649
  • 8Bendszus M, Warmuth-Metz M, Klein R. MRS in gliomatosis cerebri. Am J Neuroradiol, 2000;21:375-380
  • 9Ott D, Henning J, Ernst T. Human brain tnmors: assessment with in vivo Proton MR spectroscopy. Radiology, 1993; 186:745-752
  • 10Tedeschi G, Lundbom N, Raman R. Increased choline signalcoinciding with malignant degeneration of cerebral gliomas:a serial Proton MR spectroscopy imaging study. J Neurosurg, 1997;87:516-524

二级参考文献10

  • 1Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR, 1998, 171: 1479
  • 2Krabbe K, Gideon P, Wagn P, et al. MR diffusion imaging of human intracranial tumour. Neuroradiology, 1997, 39: 483
  • 3Tedeschi G, Lundbom N, Raman R, et al. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg, 1997, 87: 516
  • 4舆(木吕)征典,高橋睦正,生鹽之敬,等.退形成性神经胶肿的多样な MR所见.临床放射线 1999,44:1420
  • 5Ran SD. Prost E, Hanghton V, et al. Accuracy of singlevoxel proton MR specteoscopy in distinguishing neoplastic from non-neoplastic brain. AJNR Am J Neuroradiol 1997, 18:1695
  • 6清水宏明,藤原悟,吉本高志,等.脑肿病诊断にぉけズロトソMRSの现状と役割.画像诊断 1997,17:1277
  • 7Ott D, Henning J, Ernst T. Human brain tumors: assessment with in vivo proton MR spectyoscopy. Radiology, 1993, 186:745
  • 8Poptani H, Gupta, RK, Roy R, et al. Characterization of intracranial mass lesions with vivo proton MR spectroscopy. AJNR Am J Neuroradiol, 1995, 16: 1593
  • 9Sugahala T., Korogi Y, Kochi M, et al. Usefulness of diffusion-weighted MRI with echo pianar technique in the evaluation of cellularity in gliomas. JMRI, 1999, 9: 53
  • 10Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiation tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR, 2000, 21(5): 901

共引文献3

同被引文献11

  • 1Motoori K, Yamamoto S, Ueda T, et al. Interand intratumoral variability in magnetic resonance imaging of pleomorphie adenoma: an attempt to interpret the variable magnetic resonance findings. J Comput Assist Tomogr,2004 ,28 :233-246.
  • 2Patel RR, Carlos RC, Midia M, et al. Apparent diffusion coefficient mapping of the normal parotid gland and parotid involvement in patients with systemic connective tissue disorders. AJNR, 2004, 25:16-20.
  • 3Habermann CR, Graessner J, Gossrau P, et al. Diffusion-weighted echo-plannar MRI: a valuable tool for differentiating primary parotid gland tumors? Rofo, 2005,177:940-945.
  • 4Cytryn AS, Putterman AM, Schneck GL, et al. Predictability of magnetic resonance imaging in differentiation of orbital lymphoma from inflammatory syndrome. Ophthal Plast Reconstr Surg, 1997, 13 : 129-134.
  • 5Tanaka A, Mihara F, Yoshiura Y, et al. Differentiation of cavernous hemangioma from schwannoma of the orbit: a dynamic MRI study. AJR, 2004,183:1799-180d.
  • 6Ohtsuka K, Hashimoto M, Akiba H, et al. Serial dynamic magnetic resonance imaging of orbital cavernous hemangioma. Am J Ophthalmol, 1997, 123:396-398.
  • 7Wang J, Takashima S, Takayama F, et aL Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology, 2001,220:621-630.
  • 8Maeda M, Kato H, Sakuma H, et al. Usefulness of the apparent diffusion coefficient in line scan diffusion-weighted imaging for distinguishing between squamous cell carcinomas and malignant lymphomas of the head and neck. AJNR, 2005, 26 : 1186-1192.
  • 9Sadeghi N, Camby I, Goldman S, et al. Effect of hydrophilic components of the extracellular matrix on quantifiable diffusionweighted imaging of human gliomas: preliminary results of correlating apparent diffusion coefficient values and hyaluronan expression level. AJR, 2003, 181:235-241.
  • 10Dorenbeck U, Schlaier J, Bretschneider T, et al. Diffusionweighted imaging with calculated apparent diffusion coefficient in intracranial hemorrhagic lesions. Clin Imaging, 2005, 29:86-93.

引证文献1

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部